Literature DB >> 25407307

Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.

Xaioyan Xuan1, Shanshan Li, Xi Lou, Xianzhao Zheng, Yunyun Li, Feng Wang, Yuan Gao, Hongyan Zhang, Hongliu He, Qingru Zeng.   

Abstract

Stat3 alters the expression of its downstream genes and is associated with tumor invasion and metastasis in several human cancers. Its role in esophageal squamous cell carcinoma (ESCC) has not been well characterized. We examined the tumor sections of 100 cases of ESCC by immunohistochemistry and observed significant overexpression of Stat3 in the cytoplasm of 89% of ESCC cells and of phosphorylated Stat3 (p-Stat3) in the nuclei of 71% of ESCC when compare with normal esophageal mucosa (72%, p = 0.02; and 31%, p = 0.001). Overexpression of Stat3 and p-Stat3 positively correlated with that of matrix metalloproteinase-2 (MMP2), a known regulator for cell migration, in 65% of ESCC while only 26% shown in benign esophageal mucosa. To further investigate the association of Stat3 with tumor metastasis in vitro, invasion of EC-1 cells (a human ESCC cell line) were investigated with Boyden chambers. The results showed that transfection of Stat3 not only promoted invasion of EC-1 cells but also significantly induced MMP2 expression in a dose-dependent manner. In contrast, suppressing expression of endogenous Stat3 mRNA and protein by Stat3 siRNA significantly reduced EC-1 cell invasion and MMP2 expression. A high-affinity Stat3-binding element was localized to the positions of 648-641 bp (TTCTCGAA) in the MMP2 promoter with electrophoretic mobility shift assay. Our results suggest that Stat3, p-Stat3, and MMP2 were overexpressed in ESCC and associated with invasion of ESCC; and Stat3 up-regulated expression of MMP2 in ESCC through directly binding to the MMP2 promoter.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25407307     DOI: 10.1007/s11033-014-3828-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  43 in total

1.  Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.

Authors:  Cecilia J Proietti; Wendy Béguelin; María Celeste Díaz Flaqué; Florencia Cayrol; Martín A Rivas; Mercedes Tkach; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Steroids       Date:  2010-12-22       Impact factor: 2.668

Review 2.  Signal transducers and activators of transcription-from cytokine signalling to cancer biology.

Authors:  Cristina Isabel Santos; Ana P Costa-Pereira
Journal:  Biochim Biophys Acta       Date:  2011-04-05

3.  Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay.

Authors:  M G Fried
Journal:  Electrophoresis       Date:  1989 May-Jun       Impact factor: 3.535

4.  Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.

Authors:  T Kusaba; T Nakayama; K Yamazumi; Y Yakata; A Yoshizaki; T Nagayasu; I Sekine
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

5.  Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

Authors:  Shashidhar S Jatiani; Stacey J Baker; Lewis R Silverman; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2010-10

6.  The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

Authors:  A Scuto; P Krejci; L Popplewell; J Wu; Y Wang; M Kujawski; C Kowolik; H Xin; L Chen; Y Wang; L Kretzner; H Yu; W R Wilcox; Y Yen; S Forman; R Jove
Journal:  Leukemia       Date:  2010-12-17       Impact factor: 11.528

7.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

8.  Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling.

Authors:  Yuqin Che; Shuai Hou; Zhiwei Kang; Qiao Lin
Journal:  Oncol Rep       Date:  2009-08       Impact factor: 3.906

9.  Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma.

Authors:  J-C Lu; H Tao; Y-Q Zhang; W-W Zha; P-D Qian; F Li; K-X Xu
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

10.  Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility.

Authors:  Debra L Silver; Honami Naora; Jinsong Liu; Wenjun Cheng; Denise J Montell
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

View more
  19 in total

1.  Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.

Authors:  Xiao Cui; Zhi-Ping Hu; Zhao Li; Peng-Ji Gao; Ji-Ye Zhu
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

2.  Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell.

Authors:  Hong Ding; Jinglian Shen; Yang Yang; Yuqin Che
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-15       Impact factor: 2.629

3.  EZH2 enhances the invasive capability of renal cell carcinoma cells via activation of STAT3.

Authors:  Dong Zhang; Xiao-Jie Yang; Qi-Dong Luo; De-Lai Fu; Hong-Liang Li; He-Cheng Li; Peng Zhang; Tie Chong
Journal:  Mol Med Rep       Date:  2017-12-27       Impact factor: 2.952

4.  Matrix metalloproteinase promotes elastic fiber degradation in ligamentum flavum degeneration.

Authors:  Kazuki Sugimoto; Takayuki Nakamura; Takuya Tokunaga; Yusuke Uehara; Tatsuya Okada; Takuya Taniwaki; Toru Fujimoto; Hiroshi Mizuta
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

5.  Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury.

Authors:  Yafeng Liang; Nengli Yang; Guoquan Pan; Bingxin Jin; Shufen Wang; Wei Ji
Journal:  Cell Mol Biol Lett       Date:  2018-10-31       Impact factor: 5.787

6.  Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma.

Authors:  Chuying Huang; Li Wang; Xibiao Yang; Lin Lai; Dian Chen; Chunyan Duan
Journal:  World J Surg Oncol       Date:  2015-11-09       Impact factor: 2.754

7.  Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer.

Authors:  Ningning He; Guowei Feng; Yang Li; Yang Xu; Xiaoyan Xie; Hui Wang; Yuebing Wang; Lailiang Ou; Xuetao Pei; Na Liu; Zongjin Li
Journal:  Stem Cell Res Ther       Date:  2016-07-27       Impact factor: 6.832

8.  pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus.

Authors:  Katie E O' Sullivan; Adriana J Michielsen; Esther O' Regan; Mary C Cathcart; Gillian Moore; Eamon Breen; Ricardo Segurado; John V Reynolds; Joanne Lysaght; Jacintha O' Sullivan
Journal:  Int J Mol Sci       Date:  2018-06-10       Impact factor: 5.923

Review 9.  STAT3 Contributes to Radioresistance in Cancer.

Authors:  Xuehai Wang; Xin Zhang; Chen Qiu; Ning Yang
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

10.  ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.

Authors:  Asna Tungekar; Sumana Mandarthi; Pooja Rajendra Mandaviya; Veerendra P Gadekar; Ananthajith Tantry; Sowmya Kotian; Jyotshna Reddy; Divya Prabha; Sushma Bhat; Sweta Sahay; Roshan Mascarenhas; Raghavendra Rao Badkillaya; Manoj Kumar Nagasampige; Mohan Yelnadu; Harsh Pawar; Prashantha Hebbar; Manoj Kumar Kashyap
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.